Professional Documents
Culture Documents
Stroke
Stroke
HOPI:
PM/SHx;
1. Bilateral glaucoma - under clinic follow up in Penang
- on medication - eyedrops?
No previous surgery.
Drug/allergy;
- eye drops
- allergic to NSAIDS/ponstan/ibuprofen - develops periorbital oedema
Family/Social;
Mother - heart problems
father passed away
6 siblings - all well
married with one son. Husband is a pastor who works under a church organisation –
frequently travels to Sibu and Penang. Son is studying in Nottingham Uni. In
Semenyih. Patient is a kindergarden teacher also under church organisation in
Penang, was in KL for a meeting. Husband will be main carer for the patient.
Expectation is to return back to work and pre-morbid health.
PE: on admission
Alert, GCS E3V1M5, obeys command, UL/LL no drift, lungs clear
Vitals: BP 110/49, HR 81, T 36.8
Global aphasia
Able to name objects, able to obey 3-step commands, mild receptive and expressive
dysphasia (appears slow).
Able to read, difficult to write in sentences.
Peripheral visual field normal.
Mild facial asymmetry
B/L UL 4/5
B/L LL 4/5
No sensory deficit, no pronator drift, finger nose test –ve.
Currently:
Alert
Pulse – irregularly irregular
UL/LL – power 5/5, sensation intact
CVS - drnm
Lungs - clear
Dx –
Left MCA infarct with global aphasia,
newly diagnosed AF,
IHD
Ix:
RFT normal
TFT normal
CKMB – no raised cardiac markers
Lipids – raised TC/LDL
CBC & diff. – normal
HbA1C: 5.6%
CTB 27/11/18 – pre thrombolysis: no evidence of acute infarct or ICB. (may not be
seen on CT within first 48hrs)
CT brain 28/11/18: post thrombolysis – evolving left MCA territory infarct – well
defined hypodensities over left fronto-temporal lobe and insular cortex, sulci
effacement, no ICB
CTA brain 28/11/18 – evolving acute left MCA territory infarct
Mx/progression:
Day 7 in ward
- To discharge.
- Neurorehab referral. TCA neuromed D14 & repeat CT brain to start NOAC
- TCA CIHD clinic for further cardiac evaluation - angiogram
- To start single antiplatelet therapy (aspirin), cont speech therapy,
NIHSS - a quantitative measure of
stroke-related neurologic deficit